High prevalence of parkinsonism after occupational exposure to lead- sulfate batteries

Neurology

Volumn 50, Issue 6, 1998, Pages 1885-1886

  Kuhn, W ^a   Winkel, R ^a   Woitalla, D ^a   Meves, S ^a   Przuntek, H ^a   Muller T ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; LEAD SULFATE; LEAD SULFIDE; LEVODOPA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BATTERY INDUSTRY; BRADYKINESIA; CLINICAL ARTICLE; GOVERNMENT; HUMAN; LEAD POISONING; MALE; NEUROPATHY; OCCUPATIONAL EXPOSURE; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL;

EID: 0031746196     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1885     Document Type: Article

References (10)

1. Tanner CM, Langston JW. Do environmental toxins cause Parkinson's disease? A critical review. Neurology 1990; 40(suppl 3):17-31.
2. Semchuck KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43: 1173-1180.
3. Marsden CD. Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:672-681.
4. Hammond PB, Bornschein RL, Zenick H. Toxicological considerations in the assessment of lead exposure. Neurotoxicology 1984;5:53-66.
5. Lasley SM, Lane JD. Diminished regulation of mesolimbic dopaminergic activity in rat after chronic inorganic lead exposure. Toxicol Appl Pharmacol 1988;95:474-483.
6. Cory-Slechta DA, Widzowski DV. Low-level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists. Brain Res 1991;553:65-74.
7. Lawton LJ, Donaldson WE. Lead-induced tissue fatty acid alterations and lipid peroxidation. Biol Trace Elem Res 1991; 28:83-97.
8. Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. In: Golberg L, ed. CRS critical reviews in toxicology, vol 13. Boca Raton, FL: CRS Press, 1984:25-97.
9. Ho SL, McCann KP, Bennett P, et al. The molecular biology of xenobiotic enzymes and the predisposition to idiopathic Parkinson's disease. Adv Neurol 1996;69:53-60.
10. Hurwitz A, Hubble JP, Glatt SL, Koller WC, Pollak J. Erythrocyte thiolmethyltransferase: another failed marker of Alzheimer's and Parkinson's diseases. Neurology 1995;45:1903-1906.